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Abstract
Background: This cohort study compared the prognostic significance of strong ion gap (SIG) with other acid-base
markers in the critically ill.
Methods: The relationships between SIG, lactate, anion gap (AG), anion gap albumin-corrected (AG-corrected),
base excess or strong ion difference-effective (SIDe), all obtained within the first hour of intensive care unit
(ICU) admission, and the hospital mortality of 6878 patients were analysed. The prognostic significance of
each acid-base marker, both alone and in combination with the Admission Mortality Prediction Model
(MPM0 III) predicted mortality, were assessed by the area under the receiver operating characteristic
curve (AUROC).
Results: Of the 6878 patients included in the study, 924 patients (13.4 %) died after ICU admission. Except for
plasma chloride concentrations, all acid-base markers were significantly different between the survivors and
non-survivors. SIG (with lactate: AUROC 0.631, confidence interval [CI] 0.611–0.652; without lactate: AUROC 0.
521, 95 % CI 0.500–0.542) only had a modest ability to predict hospital mortality, and this was no better than
using lactate concentration alone (AUROC 0.701, 95 % 0.682–0.721). Adding AG-corrected or SIG to a
combination of lactate and MPM0 III predicted risks also did not substantially improve the latter’s ability to
differentiate between survivors and non-survivors. Arterial lactate concentrations explained about 11 % of
the variability in the observed mortality, and it was more important than SIG (0.6 %) and SIDe (0.9 %) in
predicting hospital mortality after adjusting for MPM0 III predicted risks. Lactate remained as the strongest
predictor for mortality in a sensitivity multivariate analysis, allowing for non-linearity of all acid-base markers.
Conclusions: The prognostic significance of SIG was modest and inferior to arterial lactate concentration for
the critically ill. Lactate concentration should always be considered regardless whether physiological, base
excess or physical-chemical approach is used to interpret acid-base disturbances in critically ill patients.
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Background
Acid-base disturbances due to either the underlying
pathological process or intensive care therapy are
common in critically ill patients. Broadly speaking,
there are three approaches to assess acid-base distur-
bances, including the physiological approach, the base
excess (BE) approach and the physical-chemical approach
[1]. The physiological approach uses the Henderson-
Hasselbalch equation, and arterial pH is assumed to be
solely determined by the balance between arterial carbon
dioxide tension (respiratory component) and plasma
bicarbonate concentration (metabolic component). The
BE approach has some similarities to the physiological
approach, but it uses the BE instead of bicarbonate to
define the metabolic component of acid-base distur-
bances. BE is estimated by how much acid or base is
needed to adjust the pH back to 7.40 while correcting the
arterial carbon dioxide tension to 40 mmHg. Further
refinement of these approaches includes anion gap (AG)
with and without correcting for hypoalbuminaemia
(AG-corrected) to define whether excessive anions other
than chloride (Cl−) and bicarbonate are present.
The third approach to quantify acid-base distur-
bances is the physical-chemical approach, also called
Stewart’s acid-base approach. In this approach, the
three main determinants of acid-base status are (i)
total carbon dioxide content in vitro (representing carbon
dioxide in both dissolved and undissolved forms) or
partial pressure of carbon dioxide in vivo, (ii) the
weak non-volatile acids (mainly albumin and phos-
phate) and (iii) the strong ion difference. Strong ion
difference (SID-apparent or SIDa) is the difference
between the amount of fully dissociated cations (Na+,
K+, Ca2+, Mg2+) and anions (Cl−). The physical-
chemical approach to acid-base is more comprehensive
than the other two approaches and can identify subtle or
combined acid-base disturbances that are not apparent
using the physiological or BE approach alone [2, 3].
Furthermore, recent evidence suggested that abnor-
malities in SIDa or strong ion gap (SIG) are associ-
ated with severity of inflammation, suggesting that
abnormal Stewart’s acid-base status may have patho-
genic consequences and hence prognostic significance
[4]. Stewart’s approach to acid-base disturbances is,
however, more complicated than the physiological and
BE approaches, and unless such data are automatically
generated from the laboratory, a smartphone application
may be needed to facilitate interpretation [1].
We hypothesised that SIG may be more important
than the other acid-base markers, and Stewart’s ap-
proach to acid-base disturbances may be superior to
other markers of acid-base status in predicting mor-
tality of critically ill patients [5, 6]. If this is the case,
it would be essential for SIG to be determined and
monitored regularly in critically ill patients. In this
cohort study, we compared the prognostic significance
of SIG with other commonly used acid-base markers
and determined whether SIG is better than other
acid-base markers, either by itself or when combined
with a validated prognostic model, in predicting hos-
pital mortality of the critically ill.
Methods
In this study, the physiological and biochemical data of
the patients on admission to the ICU at the Royal Perth
Hospital Intensive Care Unit (ICU) between 1 January
2008 and 31 December 2013 were analysed. Royal Perth
Hospital is a 450-bed university teaching hospital, and
the 20-bed ICU is a tertiary ICU, staffed by fully trained
intensivists, admitting critically ill adult patients of all
specialties with the exception of liver transplantation.
The dataset contained all the components of the Sim-
plified Acute Physiology Score (SAPS) III [7], Acute
Physiology and Chronic Health Evaluation (APACHE) II
score [8] and Admission Mortality Prediction Model
(MPM0 III) [9], as well as biochemical data required to
estimate AG, SIDa and SIG in the blood tests obtained
within the first hour of ICU admission [10]. The data on
SIG and SIDa were not automatically generated by the
laboratory, and none of the clinicians in the study centre
used Stewart’s approach to diagnose and manage acid-
base disturbances.
The study data were checked for transcription errors
and completeness by a designated trained clerical staff
member, using data from the computerised laboratory
database and going through the ICU vital signs flow
chart again before the data were transferred to the
computer. A single data custodian was responsible for
ensuring data quality. The data were reviewed for in-
ternal consistency, and there were no patients lost to
follow-up or with missing hospital mortality data. This
study utilised only clinical data that were de-identified
and all ICU readmissions during the same hospitalisa-
tion were excluded, was registered as a clinical audit
with the Clinical Safety and Quality Unit (150521-02)
and was exempt from review by the Royal Perth Hospital
Ethics Committee.
In this study, we compared the prognostic significance
of SIG with other commonly used acid-base markers,
including pH, carbon dioxide tension, actual (calculated)
bicarbonate, Cl−, lactate, AG, AG-corrected, actual (cal-
culated) BE, SID-effective and SIG (with [5] and without
including lactate as part of SIG [3]) (Radiometer®,
Copenhagen, Denmark), using arterial blood specimens of
the study patients all obtained within the first hour of ICU
admission. In addition, other ions that were unmeasured,
also called the ‘other’ or ‘other unmeasured ions’ [1], were
also estimated by subtracting the water, Cl− and protein
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effect from the BE. The methods to estimate and calculate
AG, AG-corrected, SIDa (with and without including
lactate in the calculations), SID-effective (SIDe), SIG (with
and without including lactate in the calculations) and
‘other unmeasured ions’ (or BE gap) are described in
Appendix 1.
Statistical analysis
After confirming that the acid-base markers did not have
an extreme U-shape relationship with the observed risks
of death (Appendix 2) which may compromise the
accuracy of the area under the receiver operating charac-
teristic curve (AUROC) analysis [11], AUROC was used
to compare the discrimination ability of different acid-
base markers. The difference in AUROC between diffe-
rent acid-base markers derived from the same patients
was calculated by the z statistic as described by Hanley
and McNeil [12]. We then assessed whether each of
these acid-base markers would improve the ability of the
MPM0 III model to predict hospital mortality of the cri-
tically ill patients by combining each of these markers
with the predicted risks of MPM0 III [13], also by
AUROC. In addition, we also assessed whether SIG
(with lactate included as part of SIG) or SIDe was supe-
rior to arterial lactate concentration in explaining the
variability in the observed hospital mortality, based on
each predictor’s chi square contribution in a multivariate
logistic regression [14], while adjusting for the MPM0 III
predicted risks. The MPM0 III prognostic model was
primarily chosen as the preferred risk adjustment model
in this study because it does not utilise any laboratory
markers of acid-base status, and hence, no one acid-base
marker was favoured in terms of its prognostic signifi-
cance due to multicollinearity with the risk adjustment
prognostic model in the AUROC and logistic regression
analyses.
Finally, four separate sensitivity analyses were per-
formed; one analysis was on patients with known cirrhosis
to assess whether SIG, SIDe or bilirubin concentration
was better than arterial lactate in predicting mortality as
this specific subgroup of patients was known to have
substantial accumulation of unmeasured anions [15, 16].
The second sensitivity analysis was conducted by re-
placing the MPM0 III predicted risks with the SAPS
III predicted risks to assess whether SIG or SIDe
would be better than lactate concentrations when a
different risk adjustment tool was used. The third sen-
sitivity analysis was to assess whether the AUROC of
the predictors that had some degree of U-shape
relationship to mortality (pH, chloride, bicarbonate and
arterial carbon dioxide tension) (Appendix 2) would
change substantially after centring these predictors [11].
In the last sensitivity analysis, we analysed all acid-base
markers in a multivariate analysis, allowing non-linearity
by a 3-knot restricted cubic spline function for all acid-
base markers [14, 17].
In this study, a p value < 0.05 was taken as signi-
ficant and all statistical analyses were performed by
SPSS for Windows (version 22.0, IBM, USA), Med-
Calc for Windows (version 12.5, Ostend, Belgium) or
S-PLUS (version 8.0, 2007; Insightful Corp., Seattle,
WA, USA).
Availability of data and materials
The SPSS dataset supporting the findings of this study
will be provided if the readers contact the corresponding
author.
Results
Of the 6878 patients included in the study (Fig. 1),
924 patients (13.4 %) died during the same hospita-
lisation after ICU admission. The patients who died
were older, with more comorbidities and a higher
acuity of acute illness (Table 1). Except for plasma
chloride concentrations, all acid-base markers on admis-
sion to the ICU were significantly different between
hospital survivors and non-survivors (Table 2).
SIG (with lactate: AUROC 0.631, confidence interval
[CI] 0.611–0.652; without lactate: AUROC 0.521, 95 %
CI 0.500–0.542) only had a modest ability to predict
hospital mortality, and this was no better than using
lactate concentration alone (AUROC 0.701, 95 % 0.682–
0.721). Arterial lactate concentration, both by itself and
in combination with the MPM0 III predicted risks
(AUROC 0.824, 95 % CI 0.809–0.839), had the strongest
ability to differentiate between survivors and non-
survivors compared to AG (AUROC 0.660, 95 % CI
0.639–0.680), AG-corrected (AUROC 0.665, 95 % CI
0.645–0.686), SID-effective (AUROC 0.634, 95 % CI
0.613–0.655), SIG-with lactate included (AUROC 0.631,
95 % CI 0.611–0.652), SIG-without including lactate
(AUROC 0.521, 95 % CI 0.500–0.542) and ‘other
unmeasured ions’ (AUROC 0.679, 95 % CI 0.658–0.700)
(all p values associated with these comparisons were <
0.01) (Table 3). Arterial lactate concentrations also had a
good calibration in predicting mortality, with a relatively
linear relationship to the risks of observed mortality
(Appendix 2). The observed hospital mortality risk of
those with an admission lactate concentration > 2
mmol/L was substantially greater than those with an ad-
mission lactate concentration ≤2 mmol/L (22.6 vs. 8.2 %,
p = 0.001).
Adding AG-corrected (AUROC 0.830, 95 % CI
0.816–0.845) or SIG-with lactate included (AUROC
0.829, 95 % CI 0.815–0.844) to a combination of
lactate and the MPM0 III predicted risks did increase
the latter’s ability to differentiate between survivors
and non-survivors statistically (AUROC 0.824, 95 %
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CI 0.809–0.839; p = 0.007 and p = 0.014, respectively),
but the magnitude of improvement was quite small
(Fig. 2).
In the multivariate logistic regression model dir-
ectly comparing the significance of arterial lactate
with SIG-with lactate included and SIDe, arterial
lactate concentrations explained about 11 % of the
variability in the observed mortality and was, by far,
more important than SIG-with lactate (0.6 %) and
SIDe (0.9 %), while adjusting for MPM0 III predicted
risks (65 %).
In the sensitivity analysis involving only patients
with known cirrhosis (n = 167), the ability of arterial
lactate (AUROC 0.734, 95 % CI 0.652–0.816) to dis-
criminate between survivors and non-survivors
remained better than SIG-with lactate (AUROC 0.644,
95 % CI 0.535–0.753), SIDe (AUROC 0.616, 95 % CI
0.518–0.714) or even bilirubin concentration (AUROC
0.604, 95 % CI 0.500–0.707). Similarly, combining
arterial lactate concentrations with SAPS III predicted
risks of mortality (AUROC 0.852) was still better than
the combination of SIG-with lactate (AUROC 0.836)
or SIDe (AUROC 0.835) with the SAPS III predicted
risks in differentiating between survivors and non-
survivors. After centring the U-shape predictors be-
fore the ROC analyses, the improvements in AUROC
for pH, chloride, bicarbonate and arterial carbon di-
oxide tension were small (all increments < 0.015) and
remained inferior to using lactate alone. When all
acid-base markers were analysed simultaneously in a
multivariate model with a 3-knot restricted cubic spline
function allowing non-linearity for all predictors in the
model, lactate explained 19 % of the variability in hospital
mortality and remained as the strongest predictor for hos-
pital mortality compared to other acid-base markers
(Fig. 3). In this direct comparison of all acid-base markers
while allowing predictors to assume a U-shape relation-
ship, chloride became the second most important acid-
base predictor (Fig. 4).
Discussion
This study showed that many markers of acid-base
status of critically ill patients on ICU admission were
significantly different between survivors and non-
survivors. Of all the acid-base markers assessed, arte-
rial lactate concentration had the best discrimination
and was better than SIG (with and without including
lactate as part of its calculations) in discriminating
between survivors and non-survivors—both when it
was analysed on its own and simultaneously with the
MPM0 III predicted risks of mortality. Adding SIG to
a combination of lactate and MPM0 III predicted
risks also did not greatly improve our ability to pre-
dict mortality of critically ill patients. These findings
are clinically relevant and require further discussion.
Evidence suggests that Stewart’s approach to acid-base
may help us to identify important metabolic acid-base
abnormalities that are not apparent by using the physio-
logical or BE approach alone [18]. There were also stu-
dies showing that SIG or SIDe could be better than BE,
AG or lactate in predicting outcomes of critically ill
patients [5, 6, 19–22]. However, many of these studies
are relatively small, with the two largest studies (invol-
ving 410 and 935 patients) both showing an insignificant
advantage by using SIG and SIDe instead of standard
markers of acid-base disturbances in predicting mortality
of critically ill patients [3, 23, 24]. To the best of our
knowledge, this is the largest study (n = 6878) assessing
the prognostic significance of SIG (with and without
including lactate) relative to 10 other acid-base markers
in a heterogeneous group of critically ill patients, and
our findings are consistent with the data from two
largest published studies [3, 23]. Indeed, both these
9549 patients admitted to the ICU 
between January 1, 2008 and  
December 31, 2013 
Admission arterial blood acid-base 
data:
pH (n= 9197)




Base excess (n= 8344)
Anion gap (n= 7863)
Anion gap albumin-corrected 
(n= 7841)
Strong ion gap (n= 7078)
Strong ion difference–effective 
(n= 7468)
Total number of patients with data 
on all 10 markers of acid-base 
status = 6878
ICU survivors (90%, n=6187) 
Hospital survivors (86.6%, n=5954)
2671 patients did 
not have complete 
data on all 10 
markers of acid-base 
status
Fig. 1 Flow chart showing inclusion and exclusion of patients in
this study
Ho et al. Journal of Intensive Care  (2016) 4:43 Page 4 of 11






(n = 924, 13.4 %)
p valuea
Age, years (IQR) 54.4 (38–69) 53.2 (36–67) 62.9 (48–75) 0.001
Male, no. (%) 4504 (66) 3930 (66) 574 (62) 0.023
ICU admission source, no. (%) 0.001
- Operating theatre 3166 (46) 2919 (49) 247 (27)
- Emergency department 1813 (26) 1508 (25) 305 (33)
- Ward 574 (8) 422 (7) 152 (16)
- CCU/HDU 286 (4) 213 (4) 73 (8)
- Other hospital 930 (14) 806 (14) 124 (13)
- Other hospital ICU 55 (1) 42 (1) 13 (1.4)
Elective surgery, no. (%) 1881 (27) 1798 (30) 83 (9) 0.001
Ward stay before ICU, days (IQR) 5 (2–10) 5 (2–10) 4 (2–13) 0.958
Mechanical ventilation on adm (%) 5412 (79) 4677 (79) 735 (80) 0.383
Acute renal failure on adm, no. (%)b 392 (6) 185 (3) 207 (22) 0.001
Worst 24-h APACHE II score (IQR) 17.0 (12–22) 16 (12–21) 27 (21–32) 0.001
SAPS III score (IQR) 43 (34–54) 41 (33–50) 60 (51–68) 0.001
SAPS III predicted risk, % (IQR) 7.9 (3–22) 6.3 (2–16) 32.8 (17–49) 0.001
MPM0 III predicted risk, % (IQR) 15.7 (8–31) 13.9 (7–26) 41.5 (22–68) 0.001
ICU stay, days (IQR) 3 (2–6) 3 (2–6) 4 (2–7) 0.001
Hospital stay, days (IQR) 13 (7–25) 14 (8–26) 6 (3–17) 0.001
Chronic medical conditions (%)b
- Respiratory 314 (5) 264 (4) 50 (5) 0.203
- Cardiovascular 679 (10) 579 (10) 100 (11) 0.313
- Liver 167 (2) 127 (2) 40 (4) 0.001
- Renal 323 (5) 244 (4) 79 (9) 0.001
- Immune disease 69 (1) 51 (0.9) 18 (2) 0.004
- Immune treatment 252 (4) 185 (3) 67 (7) 0.001
- Metastatic cancer 93 (1) 71 (1) 27 (2) 0.008
- Lymphoma 39 (0.6) 25 (0.4) 14 (2) 0.001
- Leukaemia/myeloma 83 (1) 53 (0.9) 30 (3) 0.001
- AIDS 7 (0.1) 3 (0.05) 4 (0.4) 0.008
Major admission diagnoses, no. (%)
Cardiac or respiratory arrest 345 (5) 182 (3) 163 (18) 0.001
Pneumonia 265 (4) 23 (4) 42 (5) 0.233
Septic shock 36 (6) 324 (5) 112 (12) 0.001
Multiple trauma 491 (7) 455 (8) 36 (4) 0.001
Isolated head trauma 620 (9) 526 (9) 94 (10) 0.195
Intracranial haemorrhage 235 (3) 154 (3) 81 (9) 0.001
Drug overdoses 449 (7) 441 (7) 8 (0.9) 0.001
Congestive heart failure, ischaemic heart disease or cardiogenic shock 179 (3) 129 (2) 50 (5) 0.001
Peripheral vascular disease or aortic aneurysm 205 (3) 184 (3) 21 (2) 0.211
GI obstruction or perforation 161 (2) 134 (2) 27 (3) 0.200
Aspiration pneumonia 76 (1) 68 (1) 8 (0.9) 0.611
Obstructive airway disease 136 (2) 127 (2) 9 (1) 0.015
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studies showed that lactate had the strongest ability to
differentiate between survivors and non-survivors com-
pared to SIG or SIDe (AUROC lactate: 0.67 and 0.77 vs.
AUROC SIG: 0.62 and 0.67, respectively), suggesting
that arterial lactate concentration should always be con-
sidered [1], regardless of the approach used to assess
acid-base disturbances in the critically ill. This result
also supports the hypothesis that lactate concentration is
a preferred resuscitation target in patients with critical
illness [25–27].
So, why was SIG or SIDe not better than arterial lac-
tate in predicting mortality in our patients? First of all, it
may be too simplistic to assume, by intuition, that the
prognostic significance of SIG with lactate should be
better than using lactate alone just because the former
includes lactate and also other biochemical variables.
Although the SIG has the ability to reflect acid-base
abnormalities as a result of different pathologies, its
prognostic significance can also be confounded by changes
in the underlying elements of SIG in different directions.
Lactate is an anion and an elevated lactate concen-
tration would be, at least in part, accounted for by an
abnormal SIG, or SIDe. However, hyperlactataemia
can also be ‘concealed’ with a relatively normal SIG,
bicarbonate concentration, BE or SIDe, due to coexisting
hypochloraemic alkalosis [28]. As such, by combining not
so important predictors with an important predictor of
mortality (e.g. lactate) within the calculation of SIG, it has
the potential to reduce the prognostic significance of SIG.
Furthermore, an increase in other measured and unmea-
sured anions including ketoacids, formate, oxalate, salicyl-
ate, sulphate and phosphate [1], leading to an increase in
SIG (and a decrease in SIDe) without hyperlactataemia,
also does not have the same prognostic significance as
lactic acidosis and is more amendable to specific suppor-
tive therapy that can directly improve patient outcomes.
Second, acute and chronic and liver diseases were
uncommon in our patients (2 %). Previous studies have
Table 1 Characteristics of the study cohort (Continued)
Heart valve surgery 516 (8) 503 (8) 13 (1) 0.001
Coronary artery bypass graft surgery 982 (14) 958 (16) 24 (3) 0.001
Acute lung injury or ARDS 27 (0.4) 22 (0.4) 5 (0.5) 0.398
Gastrointestinal bleeding 125 (2) 106 (2) 19 (2) 0.511
Pulmonary embolism 22 (0.3) 16 (0.3) 6 (0.6) 0.106
All values are median and interquartile range (IQR) in parenthesis unless stated otherwise
Adm admission, GI gastrointestinal, APACHE Acute Physiology and Chronic Health Evaluation, ARDS acute respiratory distress syndrome, CCU coronary care unit,
HDU high dependency unit, ICU intensive care unit, MPM0 III Mortality Prediction Model on admission, SAPS Simplified Acute Physiology Score
ap values generated by either Mann-Whitney or chi square test
bAccording to the definitions by the APACHE model
Table 2 Differences in different markers of acid-base disorders at ICU admission between survivors and non-survivors (n = 6878)
Acid-base markers Survivors (n = 5954) Non-survivors (n = 924) p valuea
1. Arterial pH 7.35 (7.29–7.39) 7.28 (7.17–7.37) 0.001
2. Arterial CO2 tension, mmHg 40 (35–45) 40 (34–48.8) 0.022
3. Actual bicarbonate conc., mmol/L 21 (19–23) 18 (14–21.8) 0.001
4. Chloride conc., mmol/L 110 (107–113) 109 (105–114) 0.891
5. Lactate conc., mmol/L 1.5 (1.0–2.4) 2.7 (1.4–5.6) 0.001
6. Actual base excess, mmol/L −3 (−6 to −1) −7 (−12 to −3) 0.001
7. Anion gap, mmol/L 12.5 (10.1–15.0) 15.0 (11.9–19.5) 0.001
8. Anion gap albumin-corrected, mmol/L 15.5 (12.8–18.5) 18.7 (14.8–23.6) 0.001
9. SIG with lactate, mmol/L 4.2 (1.5–7.1) 6.5 (3.0–10.8) 0.001
10. SIG without lactate, mmol/L 2.2 (−0.3 to 5.0) 2.5 (−0.4 to 5.8) 0.028
11. SID-effective, mmol/L 33.5 (30.5–36.2) 30.7 (26.7–34.7) 0.001
12. Other unmeasured ions, mmol/L 2.1 (−1.0 to 4.9) −1.5 (−7.3 to 2.5) 0.001
All data are median values with the interquartile range reported in parenthesis
CO2 carbon dioxide, SID strong ion difference, SIG strong ion gap
ap values generated by Mann-Whitney test
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Table 3 The areas under the receiver operating characteristic curve (AUROC) of the different markers of acid-base disorders at
ICU admission, with and without combining with Admission Mortality Prediction Model (MPM0 III) predicted risks of mortality,
in differentiating between hospital survivors and non-survivors (n = 6878)
Acid-base markers Mean AUROC (95 % confidence interval [CI])
Without MPM0 III With MPM0 III
1. Arterial pH 0.655 (0.633–0.677) 0.805 (0.789–0.821)
2. Arterial CO2 tension 0.521 (0.499–0.544) 0.798 (0.782–0.814)
3. Actual bicarbonate conc. 0.676 (0.655–0.696) 0.812 (0.796–0.828)
4. Chloride conc. 0.517 (0.495–0.539) 0.801 (0.785–0.816)
5. Lactate conc. 0.701 (0.682–0.721) 0.824 (0.809–0.839)
6. Actual base excess 0.685 (0.664–0.706) 0.813 (0.797–0.829)
7. Anion gap 0.660 (0.639–0.680) 0.813 (0.798–0.828)
8. Anion gap albumin-corrected 0.665 (0.645–0.686) 0.818 (0.803–0.833)
9. Strong ion gap (SIG) with lactate 0.631 (0.611–0.652) 0.812 (0.797–0.827)
10. SIG without lactate 0.521 (0.500–0.542) 0.801 (0.786–0.817)
11. Strong ion difference-effective 0.634 (0.613–0.655) 0.809 (0.794–0.825)
12. Other unmeasured ions 0.679 (0.658–0.700) 0.820 (0.805–0.835)
The AUROC for MPM0 III predicted risks of mortality alone was 0.799 (95 % CI 0.783–0.814) and SAPS III predicted risks alone was 0.833 (95 % CI 0.821–0.844). The
AUROC for combining lactate with anion gap albumin-corrected and MPM0 III, and combining lactate with SIG and MPM0 III were 0.830 (95 % CI 0.816–0.845) and
0.829 (95 % CI 0.815–0.844), respectively
Fig. 2 Area under the receiver operating characteristic curves (AUROC) showing improvement in discriminative ability by combining lactate with
the MPM0 III model compared to MPM0 III alone, and adding anion gap albumin-corrected or strong ion gap to lactate with MPM0 III did not
substantially further improve the latter’s ability to differentiate between survivors and non-survivors
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showed that patients with liver diseases often have accu-
mulation of unmeasured anions in addition to lactate
[15, 16]; hence, SIG and SIDe may have a stronger prog-
nostic significance than using lactate alone for these
patients. Third, we assessed the prognostic significance
of all the markers of acid-base disturbances in blood
samples obtained within the first hour of ICU admission.
It is well established that administering large quantity
of intravenous fluid to critically ill patients can alter
their acid-base status through multiple mechanisms,











Fig. 4 A U-shape relationship between plasma chloride concentrations and hospital mortality after adjusting for all other acid-base markers.
Dotted lines indicate 95 % confidence interval
0 20 40 60 80 100 120
Chi-Square Minus Degrees of Freedom
Lactate  (19%)  
Chloride (7.9%)  
CO2 (2.2%)  
pH (2.1%)  
Anion gap (0.9%)  
Unmeasured  
ions (0.8%)  
HCO3 (0.7%)  
SIG (0.6%)  
Base excess (0.4%)  
Anion gap
corrected (0.4%)  
SIDe (0.1%)  
Fig. 3 Variability in hospital mortality explained by each acid-base marker in a multivariate model including all acid-base markers and allowing
each to have a U-shape relationship with mortality by a 3-knot restricted cubic spline function. SIG strong ion gap. SIDe effective strong ion
difference, CO2 carbon dioxide, HCO3 actual bicarbonate
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including inducing hyperchloraemic acidosis and dilu-
tional hypoalbuminaemia. Whether SIG and SIDe may
have a stronger association with mortality than arterial
lactate in the later phase of critical illness after a large
quantity of intravenous fluid is used for resuscitation
remains uncertain, and this merits further evaluation.
Although ‘other unmeasured ions’ (or BE gap) is theo-
retically similar to SIG calculated without lactate and
has received considerable attention over the years [29, 30],
it is not simple to use and was not as good as lactate, both
alone and in combination with MPM0 III predicted risks,
in predicting mortality of the critically ill. In addition, our
study also showed that arterial carbon dioxide tension
(AUROC 0.521) and chloride concentrations (AUROC
0.517) were not as important as arterial lactate concen-
trations in discriminating between survivors and non-
survivors. This may be due to the fact that the underlying
causes for both respiratory acidosis and hyperchloraemia
are usually obvious to the treating clinicians and are
also more readily treatable than lactic acidosis using
mechanical ventilation and sodium bicarbonate or di-
uretics, respectively.
This study has some limitations. First, although we
had included a large number of patients and our results
were consistent with largest published studies [3, 23],
this was still a single-centre study potentially limiting its
general applicability and to different specific subgroups
of critically ill patients, especially those with acute liver
failure. Second, inherent to all diagnostic tests, noting
abnormal results from a diagnostic test is not necessarily
translatable to improved outcomes, unless the under-
lying pathological process reflected by the diagnostic test
can be identified and modified. Finally, temporal changes
in acid-base markers during the course of critical illness
and after different interventions are common and may
affect the prognostic significance of each acid-base
marker differently. Whether serial lactate concentrations
are the most important acid-base marker to be targeted
in the critically ill remains uncertain [25, 27], and this
merits further investigation.
Conclusions
In conclusion, many markers of acid-base status in cri-
tically ill patients were significantly different between
survivors and non-survivors. The prognostic significance
of SIG was modest and inferior to arterial lactate concen-
tration for the critically ill. Of all the acid-base markers
assessed in this large cohort study, arterial lactate concen-
tration had the best discrimination—both when it was
analysed on its own and simultaneously with the MPM0
III predicted risks of mortality or other acid-base markers
while allowing a U-shape relationship for all acid-base
markers—suggesting that arterial lactate concentration is
the important marker of acid-base disorders in
determining mortality outcome of critically ill patients.
Lactate concentration should always be considered re-
gardless of which approach is used to interpret acid-base
disturbances in critically ill patients; a high lactate concen-
tration can be considered as a simple, and yet, important
warning acid-base marker for patients who are at risk of




Anion gap = [Na+] + [K+] − [Cl−] − [HCO3
−]
Anion gap albumin-corrected = anion gap + 0.25 ×
(42 − observed albumin in g/L)
Strong ion difference-effective (SIDe) = [HCO3
−] +
[albumin] × (0.123 × pH − 0.631) + 2 × [phosphate] ×
(0.309 × pH − 0.469)
Strong ion difference-apparent (SIDa) = [Na+] + [K+] +
2 × [Ca2+] + 2 × [Mg2+] − [Cl−] − [lactate]
Strong ion difference-apparent (SIDa with lactate in-
cluded) = [Na+] + [K+] + 2 × [Ca2+] + 2 × [Mg2+] − [Cl−]
Strong ion gap = (strong ion difference-apparent) −
(strong ion difference-effective)
Strong ion gap with lactate included = (strong ion
difference-apparent with lactate) − (strong ion
difference-effective)
‘Other unmeasured ions’ = base excess (BE) − ‘protein
effect’ − ‘chloride effect’ − ‘water effect’ = BE − (0.148 ×
pH − 0.818) × (42 − measured albumin in g/L) − (102 −
measured [Cl−] × 140/measured [Na+]) − 0.3 ×
(measured [Na+] − 140)
Arterial blood gases including lactate, chloride concen-
trations were measured by ABL800 FLEX blood gas ana-
lyser (Radiometer®, Copenhagen, Denmark) (bias and







All concentration measurements used in the calcula-
tions are based on millimole per litre.
Appendix 2
Scatter plots showed no extreme U-shape relationships
between observed risks of mortality and different
markers of acid-base status which may substantially
compromise the receiver operating characteristic (ROC)
analyses. All error bars in the graphs in Appendix 2
signify 95 % confidence interval of the observed hospital
mortality risk for subgroup of patients with the value of
the associated acid-base marker on admission to the in-
tensive care unit (Fig. 5).
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